Sleuthful pharmacology

Molecular Pharmacology

Volumn 64, Issue 2, 2003, Pages 199-201

  Lazo, John S ^a   Ducruet, Alexander P ^a   Koldamova, Radosevda P ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUTAMYL CYSTEINE SYNTHETASE; ANTINEOPLASTIC AGENT; APOPTOSIS SIGNAL REGULATING KINASE 1; ARTEMISININ; ARTESUNATE; CARBOPLATIN; CDC25A PROTEIN; COMPLEMENTARY DNA; DACARBAZINE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; GLUTAMATE CYSTEINE LIGASE; IFOSFAMIDE; PHOSPHOTRANSFERASE; PROTEIN TYROSINE PHOSPHATASE; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CLINICAL PHARMACOLOGY; CYTOTOXICITY; DNA HYBRIDIZATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; MALARIA; MEDICAL INFORMATICS; PRIORITY JOURNAL; PUBLICATION; REVIEW;

ANTIMALARIALS; ARTEMISININS; CDC25 PHOSPHATASE; HUMANS; MAP KINASE KINASE KINASE 5; MAP KINASE KINASE KINASES; SESQUITERPENES;

EID: 0041842590     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.2.199     Document Type: Review

References (10)

1. Blomberg I and Hoffmann I (1999) Ectopic expression of Cdc25A accelerates the G1/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol 19:6183-6194.
2. Cangi MG, Cukor B, Soung P, Signoretti S, Moreira GJ, Ranashinge M, Cady B, Pagano M, and Loda M (2000) Role of the Cdc25A phosphatase in human breast cancer. J Clin Investig 106:753-761.
3. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, and Chitambar CR (2001) The anti-malarial artesunate is also active against cancer. Int J Oncol 18:767-773.
4. Efferth T, Sauerbrey A, Olbrich A, Gebhart E, Rauch P, Weber HO, Hengstler JG, Halatsch M-E, Volm M, Tew KD, et al. (2003) Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64:382-394.
5. Lyon MA, Ducruet AP, Wipf P, and Lazo JS (2002) Dual-specificity phosphatases as targets for antineoplastic agents. Nat Rev Drug Discov 1:961-976.
6. Ma ZQ, Liu Z, Ngan ES, and Tsai SY (2001) Cdc25B functions as a novel coactivator for the steroid receptors. Mol Cell Biol 21:8056-8067.
7. Wang Z, Wang M, Lazo JS, and Carr BI (2002) Identification of epidermal growth factor receptor as a target of Cdc25A protein phosphatase. J Biol Chem 277:19470-19475.
8. Xia K, Lee RS, Narsimhan RP, Mukhopadhyay NK, Neel BG, and Roberts TM (1999) Tyrosine phosphorylation of the proto-oncoprotein Raf-1 is regulated by Raf-1 itself and the phosphatase Cdc25A. Mol Cell Biol 19:4819-4824.
9. Xiao Z, Chen Z, Gunasekera AH, Sowin TJ, Rosenberg SH, Fesik S, and Zhang H (2003) Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA damaging agents. J Biol Chem, in press.
10. Zou X, Tsutsui T, Ray D, Blomquist JF, Ichijo H, Ucker DS, and Kiyokawa H (2001) The cell cycle-regulatory Cdc25A phosphatase inhibits apoptosis signal-regulating kinase 1. Mol Cell Biol 21:4818-4828.